|本期目录/Table of Contents|

[1]周小林.CRP和Alb与初诊断的非小细胞肺癌临床病理特征联系及预后价值分析[J].医学研究与战创伤救治(原医学研究生学报),2016,18(05):489-492.[doi:10.3969/j.issn.1672-271X.2016.05.012]
　ZHOU Xiao-lin.Prognostic evaluation of CRP and Alb in newly diagnosed non-small cell lung cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(05):489-492.[doi:10.3969/j.issn.1672-271X.2016.05.012]
点击复制

CRP和Alb与初诊断的非小细胞肺癌临床病理特征联系及预后价值分析()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第18卷
期数:
2016年05期
页码:
489-492
栏目:
出版日期:
2016-09-20

文章信息/Info

Title:
Prognostic evaluation of CRP and Alb in newly diagnosed non-small cell lung cancer
作者:
周小林
226000江苏南通，南通市第二人民医院呼吸科
Author(s):
ZHOU Xiao-lin
Department of Respiration, Nantong Second People’s Hospital, Nantong, Jiangsu 226000，China
关键词:
非小细胞肺癌; C反应蛋白; 血清白蛋白; 生存分析; 预后
Keywords:
non-small cell lung cancer (NSCLC);  C-reactive protein (CRP);  serum albumin (Alb);  survival analysis;  prognostic evaluation
分类号:
R734.2
DOI:
10.3969/j.issn.1672-271X.2016.05.012
文献标志码:
A
摘要:
目的 分析初诊非小细胞肺癌(NSCLC)患者血清C-反应蛋白(CRP)、血清白蛋白(Alb)水平与临床病理特征及患者总生存期的联系，探讨其在NSCLC患者预后转归的临床意义。方法 回顾性分析2011年1月－2013年1月医院收治的105例NSCLC患者的临床资料，根据患者术前外周血CRP和Alb中位值，分别分为高值组和低值组，分析CRP、Alb水平高低与临床病理特征的关系，根据随访生存情况，采用Kaplan-Meier法单因素、Cox比例风险回归模型多因素分析术前CRP、Alb等因素对NSCLC患者总生存期的影响。结果 治疗前NSCLC患者血清CRP的水平为(18.14±10.75)mg/L，Alb值为(35.32±12.83) g/L。Alb低值组与高龄、淋巴结转移、较晚的临床分期相关，而CRP高值组与淋巴结转移、较晚的临床分期相关，具有统计学意义(P＜0.05)。单因素分析显示高CRP和低Alb水平与较差的总生存期有关，多因素生存分析显示淋巴结转移，较晚的临床分期和高CRP值是影响NSCLC患者生存预后的独立危险因素。结论 CRP和Alb两项指标对肺癌的诊断、预后判断和疗效监测具有重要应用价值，是NSCLC预后潜在的生物标志物。
Abstract:
Objective To analyze the correlation of serum C-reactive protein (CRP), serum albumin (Alb) levels and clinical pathological features and clinical overall survival in newly diagnosed non-small cell lung cancer (NSCLC). To investigate the prognostic evaluation of CRP and Alb in NSCLC. Methods Clinical data of 105 newly diagnosed patients with NSCLC in our department were analyzed retrospectively. They were divided into two groups according to the levels of CRP and Alb. Clinicopathological features and levels of CRP and Alb were compared. In order to determine their prognostic value, overall survival (OS) was evaluated using the Kaplan-Meier method, and multivariate analysis was performed using the Cox proportional hazard analysis. Results The levels of CRP and Alb in newly diagnosed patients with NSCLC were （18.14±10.75）mg/L and (35.32±12.83)g/L respectively. The low Alb group and the high CRP group were related to old age, tumor lymph node metastasis and late clinical stage significantly. Univariate Kaplan-Meier analysis revealed a significant correlation between low Alb/high CRP level and poor overall survival. Furthermore, high level of CRP was an independent marker for poor clinical outcome as tumor lymph node metastasis and late clinical stage concerning the multivariate analysis of NSCLC patients. Conclusion The two indicators of CRP and Alb have important value in diagnosis, prognosis and therapeutic of NSCLC and could be the potential biomarkers in prognosis of lung cancer.

参考文献/References:

[1]Folkert MR, Timmerman R. Review of treatment options for oligometastatic non-small cell lung cancer[J]. Clin Adv Hematol Oncol, 2015, 13(3): 186-193.
[2]Yan JH, Zhao CL, Ding LB,et al. FOXD3 suppresses tumor growth and angiogenesis in non-small cell lung cancer[J]. Biochem Biophys Res Commun, 2015, 466(1):111-116.
[3]Quintyne KI, Walsh L, Coate L. Non-small-cell lung cancer: promising advances in treatment[J]. Lancet Respir Med, 2013, 1(1): e13-14.
[4]Vijayvergia N, Shah PC, Denlinger CS. Survivorship in non-small cell lung cancer: challenges faced and steps forward[J]. J Natl Compr Canc Netw, 2015, 13(9): 1151-1161.
[5]Meoni G, Cecere FL, Lucherini E,et al. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents[J]. J Geriatr Oncol, 2013, 4(3): 282-290.
[6]Kamp DW, Shacter E, Weitzman SA. Chronic inflammation and cancer: the role of the mitochondria[J]. Oncology (Williston Park), 2011, 25(5): 400-410.
[7]Rivas-Fuentes S, Salgado-Aguayo A, Pertuz Belloso S,et al. Role of chemokines in non-small cell lung cancer: angiogenesis and inflammation[J]. J Cancer, 2015, 6(10): 938-952.
[8]Scott HR, McMillan DC, Forrest LM,et al. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer[J]. Br J Cancer, 2002, 87(3): 264-267.
[9]Mantovani A. Cancer: inflaming metastasis[J]. Nature, 2009, 457(7225): 36-37.
[10]Forrest LM, McMillan DC, McArdle CS,et al. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer[J]. Br J Cancer, 2003, 89(6): 1028-1030.
[11]Liao C, Yu ZB, Meng G,et al. Association between Th17-related cytokines and risk of non-small cell lung cancer among patients with or without chronic obstructive pulmonary disease[J]. Cancer, 2015, 121 (Suppl 17):3122-3129.
[12]Chen YY, Wang LW, Wang SY,et al. Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer[J]. Onco Targets Ther, 2015, 8: 2033-2043.
[13]Antonoff MB, Hofstetter WL, Correa AM,et al. Clinical prediction of pathologic complete response in superior sulcus non-small-cell lung cancer[J]. Ann Thorac Surg, 2016,101(1):211-217.
[14]Aggarwal BB, Gehlot P. Inflammation and cancer: how friendly is the relationship for cancer patients?[J]. Curr Opin Pharmacol, 2009, 9(4): 351-369.
[15]Aggarwal BB. Inflammation, a silent killer in cancer is not so silent[J]. Curr Opin Pharmacol, 2009, 9(4): 347-350.
[16]Tolia M, Tsoukalas N, KyrgiasG,et al. Prognostic Significance of Serum Inflammatory Response Markers in Newly Diagnosed Non-Small Cell Lung Cancer before Chemoirradiation[J]. Biomed Res Int, 2015, 2015: 485732.
[17]Gupta D, Vashi PG, Lammersfeld CA,et al. Role of nutritional status in predicting the length of stay in cancer: a systematic review of the epidemiological literature[J]. Ann Nutr Metab, 2011, 59(2-4): 96-106.
[18]Hannan JL, Radwany SM, Albanese T. In-hospital mortality in patients older than 60 years with very low albumin levels[J]. J Pain Symptom Manage, 2012, 43(3): 631-637.
[19]Wang X, Han H, DuanQ,et al. Changes of serum albumin level and systemic inflammatory response in inoperable non-small cell lung cancer patients after chemotherapy[J]. J Cancer Res Ther, 2014, 10(4): 1019-1023.
[20]McKeown DJ, Brown DJ, Kelly A,et al. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer[J]. Br J Cancer, 2004, 91(12): 1993-1995.

相似文献/References:

[1]刘红娟,汪青松,管叶明,等.脑梗死患者载脂蛋白E基因多态性相关研究[J].医学研究与战创伤救治(原医学研究生学报),2012,14(03):195.
　LIU Hong-juan,WANG Qing-song,GUAN Ye-ming,et al.The polymorphism of apolipoprotein E gene in patients with cerebral infarction[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(05):195.
[2]张 凯,胡文星,赵守城,等.依折麦布联合舒洛地特对高龄冠心病和糖尿病患者调脂、抗炎作用的临床观察[J].医学研究与战创伤救治(原医学研究生学报),2012,14(05):428.
　ZHANG Kai,HU Wen-xing,ZHAO Shou-cheng,et al.Clinical observation of ezetimibe co-administration with sulodexide adjusting lipids and anti-inflammation in elderly patients with CHD and DM[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(05):428.
[3]张 迪,刘大问,吴彬彬,等.C反应蛋白对小儿呼吸道感染的诊断价值[J].医学研究与战创伤救治(原医学研究生学报),2011,13(04):361.
[4]林 杰,陈力平,肖 立,等.同型半胱氨酸、C反应蛋白与血脂相关指标对冠心病诊断的比较[J].医学研究与战创伤救治(原医学研究生学报),2011,13(06):509.
　LIN Jie,CHEN Li-ping,XIAO Li,et al.Evaluation of serum homocysteine,C-reactive protein and various lipid lipoprotein in diagnosis of coronary heart disease[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2011,13(05):509.
[5]张晓云,汪东剑,陈渠通.多脏器功能不全综合征患者血浆降钙素原测定的临床意义[J].医学研究与战创伤救治(原医学研究生学报),2010,12(04):319.
　ZHANG Xiao-yun,WANG Dong-jian,CHEN Qu-tong.The clinical significance of detection of plasma procalcitonin in patients with multiple organ dysfunction syndrome[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(05):319.
[6]周诚忠,夏炎春,夏海波.三维适形放射治疗老年非小细胞肺癌60例[J].医学研究与战创伤救治(原医学研究生学报),2009,11(01):20.
　ZHOU Cheng-zhong,XIA Yan-chun,XIA Hai-bao.Analysis of curative effect on 60 elderly non-small cell lung cancer patients treated by three-dimensional conformal radiotherapy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(05):20.
[7]洪原城,林平冬,张江灵,等.晚期非小细胞肺癌骨转移的骨相关事件 及生存分析[J].医学研究与战创伤救治(原医学研究生学报),2009,11(02):124.
　HONG Yuan-cheng,LIN Ping-dong,ZHANG Jiang-ling,et al.Skeletal-related events of skeletal metastases in advanced stage non-small cell lung cancer and survival analysis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(05):124.
[8]诸兴明,陈 阳,杜宇平,等.急性脑梗死患者血清胱抑素C和C反应蛋白水平变化的研究[J].医学研究与战创伤救治(原医学研究生学报),2014,16(03):275.[doi:10.3969/j.issn.1672-271X.2014.03.016]
　ZHU Xing-ming,CHEN Yang,DU Yu-ping,et al.Alteration of the level of serum Cys-C and CRP in patients with acute cerebral infarction[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(05):275.[doi:10.3969/j.issn.1672-271X.2014.03.016]
[9]肖 杨,彭 雯.糖尿病肾病患者心踝指数与血清C反应蛋白的相关性[J].医学研究与战创伤救治(原医学研究生学报),2014,16(03):306.[doi:10.3969/j.issn.1672-271X.2014.03.027]
[10]陈丽萍,陈 岩,张 强,等.瑞舒伐他汀序贯治疗对急性冠脉综合征患者血清缺血修饰清蛋白、C反应蛋白、髓过氧化物酶的影响[J].医学研究与战创伤救治(原医学研究生学报),2015,17(03):272.[doi:10.3969/j.issn.1672-271X.2015.03.015]
　CHEN Li-ping,CHEN Yan,ZHANG Qiang,et al.Rosuvastatin sequential therapy impact on IMA， CRP， MPO of patients with acute coronary syndrome[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(05):272.[doi:10.3969/j.issn.1672-271X.2015.03.015]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2016-12-09